首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1448537

全球自閉症譜系障礙診斷市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Autism Spectrum Disorder Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年02月01日 | 出版商:

Value Market Research | 英文 238 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球自閉症譜系障礙診斷市場需求預計將從 2023 年的 275.2 億美元增至 2032 年的近 448.2 億美元，2024-2032 年研究期間CAGR為 5.57%。

自閉症譜系障礙 (ASD) 診斷涉及評估和識別個體自閉症相關特徵。診斷過程可能包括行為觀察、訪談和標準化測試，以評估溝通技巧、社交互動和重複行為。

市場動態

自閉症譜系障礙診斷市場是由自閉症譜系障礙日益流行、意識不斷增強以及早期準確診斷的需求所推動的。這些診斷涉及一系列評估，包括行為評估、基因測試和神經影像學，以識別和表徵個體的自閉症譜系障礙。人們日益認知到早期介入對於改善自閉症譜系障礙患者預後的重要性，刺激了對可靠、全面的診斷工具的需求。此外，醫學影像技術的進步有助於準確、及時的診斷。醫療保健專業人員、教育工作者和家長對 ASD 的認知不斷提高，進一步推動了對診斷的需求。對自閉症研究和診斷開發的監管支持也在市場成長中發揮關鍵作用。此外，正在進行的研究工作著重於識別生物標記、遺傳因素和神經發育指標，旨在提高 ASD 診斷的精確度和效率，從而塑造該市場的發展軌跡。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球自閉症譜系障礙診斷市場的每個細分市場進行了包容性評估。自閉症譜系障礙診斷行業的成長和趨勢為這項研究提供了整體方法。

市場區隔

自閉症譜系障礙診斷市場報告的這一部分提供了國家和地區層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按類型

自閉症
亞斯伯格症
普遍性發展障礙（Pdd）
其他

按服務

行為方法
早期干涉
藥物
其他

按分銷管道

醫院藥房
藥局和零售藥局
網路藥局

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲自閉症譜系障礙診斷市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。自閉症譜系障礙診斷市場的主要參與者包括Quest Diagnostics、Bio-Rad Laboratories、Thermo Fisher Scientific、F. Hoffmann-La Roche Ltd、Siemens Healthineers、Abbott Laboratories、Koninklijke Philips NV（飛利浦醫療保健）、PerkinElmer Inc. 、GE醫療保健、安捷倫科技等。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：自閉症譜系障礙診斷公司的競爭格局

自閉症譜系障礙診斷市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

公司股份分析
市場集中度
Quest Diagnostics

公司簡介
公司收入
產品
最近的發展

Bio-Rad Laboratories

公司簡介
公司收入
產品
最近的發展

Thermo Fisher Scientific

公司簡介
公司收入
產品
最近的發展

F. Hoffmann-La Roche Ltd

公司簡介
公司收入
產品
最近的發展

Siemens Healthineers

公司簡介
公司收入
產品
最近的發展

Abbott Laboratories

公司簡介
公司收入
產品
最近的發展

Koninklijke Philips NV (Philips Healthcare)

公司簡介
公司收入
產品
最近的發展

PerkinElmer Inc.

公司簡介
公司收入
產品
最近的發展

GE Healthcare

公司簡介
公司收入
產品
最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR112113809

The global demand for Autism Spectrum Disorder Diagnostics Market is presumed to reach the market size of nearly USD 44.82 BN by 2032 from USD 27.52 BN in 2023 with a CAGR of 5.57% under the study period 2024 - 2032.

Autism Spectrum Disorder (ASD) Diagnostics involve the assessment and identification of autism-related characteristics in individuals. Diagnostic processes may include behavioral observations, interviews, and standardized tests to evaluate communication skills, social interactions, and repetitive behaviors.

MARKET DYNAMICS

The Autism Spectrum Disorder Diagnostics market is driven by the increasing prevalence of ASD, growing awareness, and the need for early and accurate diagnosis. These diagnostics involve a range of assessments, including behavioral evaluations, genetic testing, and neuroimaging, to identify and characterize autism spectrum disorders in individuals. The rising recognition of the importance of early intervention in improving outcomes for individuals with ASD stimulates the demand for reliable and comprehensive diagnostic tools. Additionally, advancements in medical imaging technologies contribute to accurate and timely diagnoses. The expanding awareness of ASD across healthcare professionals, educators, and parents further fuels the demand for diagnostics. Regulatory support for autism research and diagnostic development also plays a pivotal role in market growth. Moreover, ongoing research efforts focused on identifying biomarkers, genetic factors, and neurodevelopmental indicators aim to enhance the precision and efficiency of ASD diagnostics, shaping the trajectory of this market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of autism spectrum disorder diagnostics. The growth and trends of autism spectrum disorder diagnostics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the autism spectrum disorder diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Autistic Disorder
Asperger Syndrome
Pervasive Development Disorder (Pdd)
Other

By Service

Behavioral Approaches
Early Intervention
Medication
Other

By Distribution Channe

Hospital Pharmacies
Drug Stores And Retail Pharmacies
Online Pharmacies

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Autism Spectrum Disorder Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Autism Spectrum Disorder Diagnostics market include Quest Diagnostics, Bio-Rad Laboratories, Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd, Siemens Healthineers, Abbott Laboratories, Koninklijke Philips N.V. (Philips Healthcare), PerkinElmer Inc., GE Healthcare, Agilent Technologies, and others. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . AUTISM SPECTRUM DISORDER DIAGNOSTICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Service
- 3.7.3 Market Attractiveness Analysis By Distribution Channe
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL AUTISM SPECTRUM DISORDER DIAGNOSTICS MARKET ANALYSIS BY TYPE

5.1 Overview by Type
5.2 Historical and Forecast Data
5.3 Analysis by Type
5.4 Autistic Disorder Historic and Forecast Sales by Regions
5.5 Asperger Syndrome Historic and Forecast Sales by Regions
5.6 Pervasive Development Disorder (PDD) Historic and Forecast Sales by Regions
5.7 Other Historic and Forecast Sales by Regions

6 . GLOBAL AUTISM SPECTRUM DISORDER DIAGNOSTICS MARKET ANALYSIS BY SERVICE

6.1 Overview by Service
6.2 Historical and Forecast Data
6.3 Analysis by Service
6.4 Behavioral Approaches Historic and Forecast Sales by Regions
6.5 Early Intervention Historic and Forecast Sales by Regions
6.6 Medication Historic and Forecast Sales by Regions
6.7 Other Historic and Forecast Sales by Regions

7 . GLOBAL AUTISM SPECTRUM DISORDER DIAGNOSTICS MARKET ANALYSIS BY DISTRIBUTION CHANNE

7.1 Overview by Distribution Channe
7.2 Historical and Forecast Data
7.3 Analysis by Distribution Channe
7.4 Hospital Pharmacies Historic and Forecast Sales by Regions
7.5 Drug Stores and Retail Pharmacies Historic and Forecast Sales by Regions
7.6 Online Pharmacies Historic and Forecast Sales by Regions

8 . GLOBAL AUTISM SPECTRUM DISORDER DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE AUTISM SPECTRUM DISORDER DIAGNOSTICS COMPANIES

9.1. Autism Spectrum Disorder Diagnostics Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF AUTISM SPECTRUM DISORDER DIAGNOSTICS INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Quest Diagnostics
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Bio-Rad Laboratories
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Thermo Fisher Scientific
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. F. Hoffmann-La Roche Ltd
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Siemens Healthineers
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Abbott Laboratories
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Koninklijke Philips N.V. (Philips Healthcare)
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. PerkinElmer Inc.
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. GE Healthcare
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments